Fiber-Boost Randomized Controlled Trial

In the present study 'Fiber-Boost', we investigate how a high-fiber diet affects the immunotherapy of advanced lung cancer and what effects it has on the gut microbiome (i.e., the bacteria in the gut) as well as the immune system. Study participants will be assigned to either a test group or a control group. Only patients in the test group will undergo a high-fiber diet. The study lasts 6 weeks per patient and will be conducted at 4 centers within Switzerland. A total of 42 patients are planned to be included in the study.

Trial Details

NCT ID
NCT07483112
Phase
NA
Sponsor
Cantonal Hospital of St. Gallen
Status
RECRUITING
Cancer Type
Lung Cancer
Interventions
  • High-fiber diet
Locations (sample)
  • Basel, Switzerland|47.55839,7.57327
  • Chur, Switzerland|46.84986,9.53287
  • Sankt Gallen, Switzerland|47.42391,9.37477
  • Winterthur, Switzerland|47.50564,8.72413

Key Eligibility Criteria

  • Age ≥18 years
  • Written informed consent according to Swiss law and ICH/GCP regulations before inclusion and prior to any trial-specific procedures
  • Histologically or cytologically confirmed NSCLC
  • Advanced or recurrent NSCLC not amenable to curative treatment

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lung Cancer Trials on Trialify →